The Drug Enforcement Administration (DEA) is “likely” to approve a recommendation from the Biden administration to reclassify marijuana under the nation’s drug laws, according to a report issued by congressional researchers. The report, which was released by the Congressional Research Service, comes after a recommendation from the Department of Health and Human Services in August that calls for cannabis to be rescheduled under the federal Controlled Substances Act. If approved by the DEA, rescheduling marijuana would have sweeping implications for federal policy regarding cannabis, including effects on housing, immigration, gun rights, taxation of marijuana businesses and more.  Read the article here.